Affiliation:
1. Department of Applied Pharmacy, Department of Pharmacy, Medical University of Lodz, Lodz, Poland
2. College of Cosmetology and Health Sciences, Lodz, Poland
Abstract
Lipoic acid (LA) is a natural compound present in food and used as a dietary supplement. LA is endogenously synthetized in small amounts from octanoid acid in the mitochondria. This compound occurs naturally in vegetables such as spinach, broccoli and in animal tissues, in the kidneys, heart and liver. It has been shown that LA is a cofactor in the multienzyme complexes that are responsible for oxidative decarboxylation of α- ketoacids. LA and its reduced form, dihydrolipoic acid (DHLA), have many biological functions leading to a wide variety of actions such as anti-inflammation and antioxidant protection, scavenging of reactive oxygen species, regenerating other antioxidant agents, such as vitamins C and E, and cytosolic glutathione, chelating the transitional metal ions (e.g. iron and copper), and modulating the signal transduction of nuclear factor. Many authors regard LA as a potentially useful agent in the treatment and/or prevention of many diseases such as diabetes mellitus, overweight, obesity, hypertension, heart diseases, inflammation. This review concentrates on the role of LA in the treatment of diabetes mellitus, obesity, inflammation and blood pressure regulation. LA can be considered as a potentially useful drug in treatment of many diseases, particularly those related to excessive production of free radicals.
Subject
Infectious Diseases,Microbiology (medical)
Reference100 articles.
1. Abdali D., Samson S.E., Grover A.K.: How effective are antioxidantsupplements in obesity and diabetes? Med. Princ. Pract., 2015;24: 201–215
2. Alexopoulos N., Katritsis D., Raggi P.: Visceral adipose tissue as asource of inflammation and promoter of atherosclerosis. Atherosclerosis,2014; 233: 104–112
3. Allison S.J.: Hypertension: Oxidative stress and immune activationin hypertension. Nat. Rev. Nephrol., 2016; 12: 4
4. Ametov A.S., Barinov A., Dyck P.J., Hermann R., Kozlova N., LitchyW.J., Low P.A., Nehrdich D., Novosadova M., O’Brien P.C., ReljanovicM., Samigullin R., Schutte K., Strokov I., Tritschler H.J., et al.: Thesensory symptoms of diabetic polyneuropathy are improved withα-lipoic acid. The SYDNEY Trial. Diabetes Care, 2003; 26: 770–776
5. Ansar H., Mazloom Z., Kazemi F., Hejazi N.: Effect of α-lipoic acidon blood glucose, insulin resistance and glutathione peroxidase oftype 2 diabetic patients. Saudi Med. J., 2011; 32: 584–588